Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Females aged 25 to 40 years old. 2)Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study.
Exclusion criteria
Exclusion criteria: 1)Subjects who have smoking habit. 2)Subjects who are cold-sensitive constitution. 3)Subjects who are receiving medical treatment of sleep, mental, immune. 4)Subjects who are currently receiving medication due to treatment of disease. 5)In the past month, subjects who have had custom of taking or applying medicine for the treatment of diseases. 6)Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 7)Subjects with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more. 8)Subjects who have symptom of dermatologic disease such as atopic dermatitis. 9)Subjects who have undergone surgery on investigation objective portion within the past 6 months. 10)Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within a month prior to the current study. 11)Subjects who themselves and/or their family are working for a company that develops, manufactures or sells health/functional foods and cosmetics. 12)Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 13)Males who donated over 400mL blood within the last three month to the current study. 14)Females who donated over 400mL blood within the last four month to the current study. 15)Males who will be collected over 1200mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 16)Females who will be collected over 800mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 17)Heavy alcohol drinker. 18)Others those have been determined ineligible by investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of psychology, evaluation of function of auto nervous system and central nervous system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of immuno-ability, inflammation and cognitive function. | — |
Countries
Japan
Contacts
CPCC Company Limited Planning & Sales Department